CK Life Sciences Int'l. (Holdings) Inc
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; m… Read more
Market Cap & Net Worth: CK Life Sciences Int'l. (Holdings) Inc (LSI)
CK Life Sciences Int'l. (Holdings) Inc (F:LSI) has a market capitalization of $853.37 Million (€831.36 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #14695 globally and #1512 in its home market, demonstrating a 3.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CK Life Sciences Int'l. (Holdings) Inc's stock price €0.09 by its total outstanding shares 9611073000 (9.61 Billion).
CK Life Sciences Int'l. (Holdings) Inc Market Cap History: 2015 to 2026
CK Life Sciences Int'l. (Holdings) Inc's market capitalization history from 2015 to 2026. Data shows growth from $237.76 Million to $853.37 Million (13.05% CAGR).
CK Life Sciences Int'l. (Holdings) Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CK Life Sciences Int'l. (Holdings) Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
CK Life Sciences Int'l. (Holdings) Inc's market cap is 0.08 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $237.76 Million | $4.92 Billion | $218.86 Million | 0.05x | 1.09x |
| 2016 | $274.26 Million | $4.87 Billion | $251.97 Million | 0.06x | 1.09x |
| 2017 | $239.73 Million | $4.69 Billion | $258.40 Million | 0.05x | 0.93x |
| 2018 | $175.61 Million | $5.23 Billion | $263.00 Million | 0.03x | 0.67x |
| 2019 | $596.86 Million | $4.97 Billion | $181.74 Million | 0.12x | 3.28x |
| 2020 | $602.78 Million | $4.94 Billion | $125.23 Million | 0.12x | 4.81x |
| 2021 | $612.65 Million | $5.40 Billion | $162.80 Million | 0.11x | 3.76x |
| 2022 | $812.92 Million | $5.28 Billion | $131.96 Million | 0.15x | 6.16x |
| 2023 | $651.12 Million | $5.32 Billion | $17.25 Million | 0.12x | 37.75x |
| 2024 | $439.01 Million | $5.52 Billion | -$126.55 Million | 0.08x | N/A |
Competitor Companies of LSI by Market Capitalization
Companies near CK Life Sciences Int'l. (Holdings) Inc in the global market cap rankings as of March 18, 2026.
Key companies related to CK Life Sciences Int'l. (Holdings) Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
CK Life Sciences Int'l. (Holdings) Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, CK Life Sciences Int'l. (Holdings) Inc's market cap moved from $237.76 Million to $ 853.37 Million, with a yearly change of 13.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €853.37 Million | -1.14% |
| 2025 | €863.23 Million | +96.63% |
| 2024 | €439.01 Million | -32.58% |
| 2023 | €651.12 Million | -19.90% |
| 2022 | €812.92 Million | +32.69% |
| 2021 | €612.65 Million | +1.64% |
| 2020 | €602.78 Million | +0.99% |
| 2019 | €596.86 Million | +239.89% |
| 2018 | €175.61 Million | -26.75% |
| 2017 | €239.73 Million | -12.59% |
| 2016 | €274.26 Million | +15.35% |
| 2015 | €237.76 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CK Life Sciences Int'l. (Holdings) Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $853.37 Million USD |
| MoneyControl | $853.37 Million USD |
| MarketWatch | $853.37 Million USD |
| marketcap.company | $853.37 Million USD |
| Reuters | $853.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.